Literature DB >> 29936639

Dementia Care at End of Life: Current Approaches.

Mairead M Bartley1, Laura Suarez2, Reem M A Shafi2, Joshua M Baruth2, Amanda J M Benarroch2, Maria I Lapid3,4.   

Abstract

PURPOSE OF REVIEW: Dementia is a progressive and life-limiting condition that can be described in three stages: early, middle, and late. This article reviews current literature on late-stage dementia. RECENT
FINDINGS: Survival times may vary across dementia subtypes. Yet, the overall trajectory is characterized by progressive decline until death. Ideally, as people with dementia approach the end of life, care should focus on comfort, dignity, and quality of life. However, barriers prevent optimal end-of-life care in the final stages of dementia. Improved and earlier advanced care planning for persons with dementia and their caregivers can help delineate goals of care and prepare for the inevitable complications of end-stage dementia. This allows for timely access to palliative and hospice care, which ultimately improves dementia end-of-life care.

Entities:  

Keywords:  Advanced care planning; Hospice; Late-stage dementia; Palliative care; Prognostication

Mesh:

Year:  2018        PMID: 29936639     DOI: 10.1007/s11920-018-0915-x

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  96 in total

1.  Survival and comfort after treatment of pneumonia in advanced dementia.

Authors:  Jane L Givens; Richard N Jones; Michele L Shaffer; Dan K Kiely; Susan L Mitchell
Journal:  Arch Intern Med       Date:  2010-07-12

2.  Caregiver burden in end-of-life care: advanced cancer and final stage of dementia.

Authors:  Gema Costa-Requena; M Carmen Espinosa Val; Ramon Cristòfol
Journal:  Palliat Support Care       Date:  2014-03-10

3.  Effect of the Goals of Care Intervention for Advanced Dementia: A Randomized Clinical Trial.

Authors:  Laura C Hanson; Sheryl Zimmerman; Mi-Kyung Song; Feng-Chang Lin; Cherie Rosemond; Timothy S Carey; Susan L Mitchell
Journal:  JAMA Intern Med       Date:  2017-01-01       Impact factor: 21.873

4.  Interventions Associated With the Management of Suspected Infections in Advanced Dementia.

Authors:  Elizabeth Yates; Susan L Mitchell; Daniel Habtemariam; Alyssa B Dufour; Jane L Givens
Journal:  J Pain Symptom Manage       Date:  2015-07-11       Impact factor: 3.612

5.  Clinical and organizational factors associated with feeding tube use among nursing home residents with advanced cognitive impairment.

Authors:  Susan L Mitchell; Joan M Teno; Jason Roy; Glen Kabumoto; Vincent Mor
Journal:  JAMA       Date:  2003-07-02       Impact factor: 56.272

6.  Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia.

Authors:  Oskar H Sommer; Olav Aga; Milada Cvancarova; Inge C Olsen; Geir Selbaek; Knut Engedal
Journal:  Dement Geriatr Cogn Disord       Date:  2009-02-02       Impact factor: 2.959

7.  Profiles of older medicare decedents.

Authors:  June R Lunney; Joanne Lynn; Christopher Hogan
Journal:  J Am Geriatr Soc       Date:  2002-06       Impact factor: 5.562

8.  Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial.

Authors:  David L Sultzer; Sonia M Davis; Pierre N Tariot; Karen S Dagerman; Barry D Lebowitz; Constantine G Lyketsos; Robert A Rosenheck; John K Hsiao; Jeffrey A Lieberman; Lon S Schneider
Journal:  Am J Psychiatry       Date:  2008-06-02       Impact factor: 18.112

9.  Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled Trial.

Authors:  Geke A H van den Elsen; Amir I A Ahmed; Robbert-Jan Verkes; Ton Feuth; Marjolein A van der Marck; Marcel G M Olde Rikkert
Journal:  Am J Geriatr Psychiatry       Date:  2015-07-30       Impact factor: 4.105

10.  The burden of health care costs for patients with dementia in the last 5 years of life.

Authors:  Amy S Kelley; Kathleen McGarry; Rebecca Gorges; Jonathan S Skinner
Journal:  Ann Intern Med       Date:  2015-10-27       Impact factor: 25.391

View more
  6 in total

1.  Effect of providing purple sweet potato water extract on tumor necrosis factor-α levels, protein 53 expression, glial fibrillary acidic protein expression, brain-derived neurotrophic factor levels, and spatial working memory in rats with d-galactose induction.

Authors:  Ketut Widyastuti; Tjokorda Gde Bagus Mahadewa; Dewa Ngurah Suprapta; Anak Agung Raka Sudewi
Journal:  Dement Neuropsychol       Date:  2022-06-06

2.  Junior medical doctors' decision making when using advance care directives to guide treatment for people with dementia: a cross-sectional vignette study.

Authors:  Amy Waller; Jamie Bryant; Alison Bowman; Ben P White; Lindy Willmott; Robert Pickles; Carolyn Hullick; Emma Price; Anne Knight; Mary-Ann Ryall; Mathew Clapham; Rob Sanson-Fisher
Journal:  BMC Med Ethics       Date:  2022-07-14       Impact factor: 2.834

Review 3.  Euthanasia in Dementia: A Narrative Review of Legislation and Practices in the Netherlands and Belgium.

Authors:  Radboud M Marijnissen; Kenneth Chambaere; Richard C Oude Voshaar
Journal:  Front Psychiatry       Date:  2022-06-02       Impact factor: 5.435

4.  Accuracy of two prognostic indexes to predict mortality in older adults with advanced dementia.

Authors:  Beatriz Noele Azevedo Lopes; Flavia Barreto Garcez; Claudia Kimie Suemoto; Lilian Schafirovits Morillo
Journal:  Dement Neuropsychol       Date:  2022 Jan-Mar

5.  Expert Consensus on the Care and Management of Patients with Cognitive Impairment in China.

Authors:  Yuliang Han; Jianjun Jia; Xia Li; Yang Lv; Xuan Sun; Shanshan Wang; Yongjun Wang; Zhiwen Wang; Jintao Zhang; Jiong Zhou; Yuying Zhou
Journal:  Neurosci Bull       Date:  2019-12-02       Impact factor: 5.271

6.  "It is always me against the Norwegian system." barriers and facilitators in accessing and using dementia care by minority ethnic groups in Norway: a qualitative study.

Authors:  Elżbieta Anna Czapka; Mette Sagbakken
Journal:  BMC Health Serv Res       Date:  2020-10-15       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.